Aurobindo Pharma SWOT Analysis
Here is a detailed SWOT analysis of Aurobindo Pharma covering strengths, weaknesses, opportunities and threats.
Aurobindo Pharma Strengths
- A new drug Nevirapine discovered against the HIV infective disease has been approved by the US FDA, which will increase the market size and profits of the company.
- Approval of generic version of Clopidogrel from FDA will boost revenue of company
- A greater growth in terms of sales in the US and Europe due to various US approvals
- Strong marketing network
- Aurobindo exports to over 125 countries across the globe
Above are the strengths in the SWOT Analysis of Aurobindo Pharma. The strengths of Aurobindo Pharma looks at the key internal factors of its business which gives it competitive advantage in the market and strengthens its position.
Aurobindo Pharma Weaknesses
- Retirement of the three top most directors will have an impact on the functioning till new capable people join.
- The company is not into mergers or acquisitions which will help it increase the product list
- Very low in the corporate social front
- Largely dependant on Indian market for revenue generation
These were the weaknesses in the Aurobindo Pharma SWOT Analysis. The weaknesses of a brand are certain aspects of its business which it can improve.
Aurobindo Pharma Opportunities
- Increasing health awareness
- improving the R&D section to expand the product pipeline
- Globalize and further break through into joint ventures and subsidiaries into China, Brazil and other Latin American markets.
Above we covered the opportunities in Aurobindo Pharma SWOT Analysis. The opportunities for any brand can include prospects of future growth.
Read more about Aurobindo Pharma
Aurobindo Pharma Threats
- The European crisis, which will have a great impact on the sales since major orders are from the Europe and US
- Depreciating value of currency will affect the export
- Peers post a major competition.
The threats in the SWOT Analysis of Aurobindo Pharma are as mentioned above. The threats for any business can be external factors which can negatively impact its business.
Hence this concludes the Aurobindo Pharma SWOT analysis.
Read Similar SWOT analysis
About Aurobindo Pharma
The table below gives the brand overview along with its target market, segmentation, positioning & USP
| Aurobindo Pharma Overview | |
|---|---|
| Parent Company |
Aurobindo Pharma |
| Category |
Pharmaceutical |
| Sector | |
| Tagline/ Slogan |
Committed to healthier life! |
| USP |
Among the largest 'Vertically Integrated' pharmaceutical companies in India, with a robust product portfolio |
| Aurobindo Pharma STP | |
| Segmentation |
CVS, Antibiotics, Gastroenterologicals, Anti-Diabetics , Anti-Allergic Anti-Retroviral and CNS |
| Target Market |
Patients and doctors who seek good health |
| Positioning |
They are global pharmaceutical company with great commitment to healthier life |
Browse marketing analysis of more brands and companies similar to Aurobindo Pharma. This section covers SWOT Analysis along with Segmentation, Target Market, Positioning & USP of more than 2000 brands from over 20 industry sectors.
Continue Reading:
The brand names and other brand information used in the SWOT Analysis section are properties of their respective companies. The companies are not associated with MBA Skool in any way.
Edit the brand or add a new one to SWOT Analysis section : Contribute
